PRKG1 and breast neoplasm: In Her2/Neu driven breast tumors (Figure S10A), the glycolysis data suggests inhibition of PFK1 (rather than aldolase as noted for the lung tumors) and PGK (similar to lung data) and little impact on the TCA cycle (Figure S10B), also in contrast to the lung tumor data.